
Photo: INS Vikrant and INS Vikramaditya, Indian Navy, GODL-India
UPSC Civil Services (Main) 2022 · GS Paper III
UPSC Mains 2022 GS 3 · Q16: model answer
General Studies Paper III: Technology, Economic Development, Bio-diversity, Environment, Security and Disaster Management · Science and Technology.
What is the basic principle behind vaccine development? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines?
Syllabus: Science and Technology · Biotechnology and health technology
VaccineActive immunityImmunological memoryVaccine platforms
A vaccine is a biological preparation that trains the immune system to recognise a pathogen without causing the disease, producing active immunity and lasting immunological memory. Since Edward Jenner's smallpox vaccine (1796), vaccines have eradicated smallpox and nearly eliminated polio. India, which makes nearly 60% of the world's vaccines, developed and produced several COVID-19 vaccines on different platforms.
1. Basic principle of vaccine development
- Mimic infection safely: present an antigen (a killed or weakened microbe, one of its proteins, or the genetic code for that protein) so that the immune system responds as it would to infection.
- Choose the right antigen: most COVID-19 vaccines targeted the spike protein, which SARS-CoV-2 uses to enter human cells.
- Boost the response: adjuvants such as alum strengthen and prolong immunity.
- Prove safety and efficacy: laboratory and animal studies, then Phase I (safety), Phase II (dose and immune response) and Phase III (efficacy in large groups) trials, licensing by the regulator (CDSCO in India) and post-marketing surveillance.
- Scale and stability: the vaccine must be mass-produced and stay stable in a cold chain, often at 2–8 °C.
2. How vaccines work
- Antigen presentation: dendritic cells and other antigen-presenting cells take up the antigen and display it to helper T cells.
- Antibodies: activated B cells produce antibodies that neutralise the virus and block its entry into cells.
- Cell-mediated immunity: cytotoxic (killer) T cells learn to destroy infected cells.
- Memory: memory B and T cells persist, so a later infection meets a fast, strong response that prevents severe disease.
- Herd immunity: when enough people are immune, transmission falls and the vulnerable are protected.
3. Approaches adopted by Indian manufacturers
| Approach | Vaccine and maker | Key feature |
|---|---|---|
| Inactivated whole virus | Covaxin (Bharat Biotech with ICMR-NIV) | Virus isolated in India, grown and killed |
| Viral vector | Covishield (Serum Institute; Oxford-AstraZeneca design) | Harmless chimpanzee adenovirus carries the spike gene |
| Nasal viral vector | iNCOVACC (Bharat Biotech) | India's first nasal COVID-19 vaccine |
| DNA | ZyCoV-D (Zydus) | World's first human DNA vaccine (2021); needle-free |
| Protein subunit | Corbevax (Biological E) | Receptor-binding part of the spike, made in yeast |
| mRNA | GEMCOVAC (Gennova) | India's first mRNA vaccine; kept at 2–8 °C |
- Indigenous development: Covaxin used a virus strain isolated by ICMR's National Institute of Virology, Pune; ZyCoV-D and GEMCOVAC built new DNA and mRNA platforms at home.
- Partnerships and scale: licensing global designs (Oxford-AstraZeneca for Covishield, Novavax for Covovax, Sputnik V with Dr. Reddy's) and using India's large manufacturing base.
- Government support: Mission COVID Suraksha (₹900 crore, 2020) through the Department of Biotechnology and BIRAC, emergency-use approvals, parallel trials and production, and the CoWIN platform; over 220 crore doses were given, and vaccines went abroad under Vaccine Maitri.
India's COVID-19 experience showed the value of multiple vaccine platforms, strong manufacturing and public research. Investing in mRNA, DNA and other new platforms now is the best preparation for the next pandemic.
The ₹149 All-in-One Pass opens the rest of the site for 12 months: UPSC Prelims GS Paper I and CSAT with explanations, practice quizzes and timed tests, UPSC CAPF and EPFO, the previous papers of every APPSC, TSPSC, police and SSC exam, every mock test series and the study books.
₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking